Mixed Dyslipidemias Recruiting Phase Trials for Ezetimibe (DB00973)

Also known as: Mixed Hyperlipidaemia / Mixed Dyslipidemia / Mixed Hyperlipidemia / Mixed hypercholesterolemia / Broad- or floating-betalipoproteinemia / Type V hyperlipidaemia / Type V hyperlipidemia / Type V lipidaemia / Type V lipidemia / Hyperlipoproteinemia Type V / Type V hyperlipoproteinemia / Fredrickson Type V lipidemia / Fredrickson Type V lipidaemia / Type V hyperlipoproteinaemia

IndicationStatusPhase
DBCOND0073163 (Mixed Dyslipidemias)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04579367Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia